Oklahoma Senate Bill SB1753

Oklahoma 2024 Regular Session

• Introduced: 2/5/24
• Refer: 2/6/24

Caption

Medical marijuana; directing promulgation of rules to impose tetrahydrocannabinol (THC) potency limits; prohibiting sale of certain products. Effective date.

Impact

One significant aspect of SB1753 is its specific stipulation regarding the sale of products to minors. For patients aged 18 and younger, the bill allows the Executive Director to set even stricter THC limits for edible products and outright bans vaping products for this demographic. This change is aimed at providing additional protections for younger medical marijuana patients, acknowledging the potential for heightened sensitivity to THC in adolescents.

Summary

Senate Bill 1753 introduces regulations concerning medical marijuana in Oklahoma, focusing particularly on imposing limits on the tetrahydrocannabinol (THC) potency of medical marijuana products. The bill directs the Executive Director of the Oklahoma Medical Marijuana Authority to establish rules regarding the maximum THC content allowed for edible medical marijuana products, setting an upper limit of 1,000 milligrams of THC per package. Dispensaries selling these products will be prohibited from exceeding these newly established potency limits.

Contention

Discussion around SB1753 may arise from the concerns regarding local dispensaries' operational flexibility under these new regulations. Supporters of the bill may argue that implementing stringent potency limits is a necessary public health measure aimed at ensuring safer consumption practices among patients. However, critics may view these provisions as overly restrictive, potentially affecting the availability of products needed by patients, especially those who have grown accustomed to certain potencies that align with their therapeutic needs.